Steven M Larson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Steven M Larson

Showing results (251-260 of 300) with videos related to

Pageof 30

Sort By:

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026

Preclinical 203/212Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer XenograftsBrett A Vaughn, Darren R Veach, Daniela Burnes Vargas, et al.

The Prostate|September 1, 2020

Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meetingAndrea K Miyahira, Kenneth J Pienta, John W Babich, et al.

Bioconjugate Chemistry|April 5, 2021

Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy ApplicationsMegan M Dacek, Darren R Veach, Sarah M Cheal, et al.

Nature Biotechnology|March 26, 2003

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytesGuenther Koehne, Mikhail Doubrovin, Ekaterina Doubrovina, et al.

European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2009

The risk of exaggerated risk aversion-a life and death struggle for molecular imagingBengt Långström, Anders Grahnen, Per Hartvig Honoré, et al.

Molecular Pharmaceutics|April 24, 2018

ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor XenograftsSarah M Cheal, Shutian Ruan, Darren R Veach, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 14, 2020

Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapyMesude Bicak, Katharina Lückerath, Teja Kalidindi, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020

A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted RadioimmunotherapyBrian H Santich, Sarah M Cheal, Mahiuddin Ahmed, et al.

Cancer Research|October 6, 2005

Targeted elimination of prostate cancer by genetically directed human T lymphocytesTerence P F Gade, Waleed Hassen, Elmer Santos, et al.

Theranostics|August 4, 2025

Comparison of targeting two antigens (GPA33 versus HER2) for 225Ac-pretargeted alpha-radioimmunotherapy of colorectal cancerSara S Rinne, Daniela Burnes Vargas, Brett A Vaughn, et al.

Pageof 30

Search research articles

Showing results (251-260 of 300) with videos related to

Sort By:

Pageof 30

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026

The Prostate|September 1, 2020

Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meetingAndrea K Miyahira, Kenneth J Pienta, John W Babich, et al.

Bioconjugate Chemistry|April 5, 2021

Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy ApplicationsMegan M Dacek, Darren R Veach, Sarah M Cheal, et al.

Nature Biotechnology|March 26, 2003

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytesGuenther Koehne, Mikhail Doubrovin, Ekaterina Doubrovina, et al.

European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2009

The risk of exaggerated risk aversion-a life and death struggle for molecular imagingBengt Långström, Anders Grahnen, Per Hartvig Honoré, et al.

Molecular Pharmaceutics|April 24, 2018

ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor XenograftsSarah M Cheal, Shutian Ruan, Darren R Veach, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 14, 2020

Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapyMesude Bicak, Katharina Lückerath, Teja Kalidindi, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020

A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted RadioimmunotherapyBrian H Santich, Sarah M Cheal, Mahiuddin Ahmed, et al.

Cancer Research|October 6, 2005

Targeted elimination of prostate cancer by genetically directed human T lymphocytesTerence P F Gade, Waleed Hassen, Elmer Santos, et al.

Theranostics|August 4, 2025

Comparison of targeting two antigens (GPA33 versus HER2) for 225Ac-pretargeted alpha-radioimmunotherapy of colorectal cancerSara S Rinne, Daniela Burnes Vargas, Brett A Vaughn, et al.

Pageof 30